Skip to content

Two-year budget deal reached in Senate

Today, the Senate reached a far-reaching bipartisan budget agreement that would set top-line spending limits for FY2018 and FY2019, which would be added to the continuing resolution (CR) passed by the House.  The spending levels for the two years represent significant increases above what is currently allowed under the budget caps that were created in 2011.

Under the agreement, funding for non-defense discretionary programs would be increased by $63 billion in FY2018 and $68 billion in FY2019 while defense programs would see increases of $80 billion and $85 billion, respectively.

In addition, the deal includes an additional $2 billion for the National Institutes of Health over the next two years while also providing approximately $6 billion for the opioid crisis.  The agreement calls for $20 billion in infrastructure investment among its other provisions.

The deal does not address Dreamers and House Minority Leader Nancy Pelosi (D-CA) announced earlier in the day that she would not support any funding deal until she gets a commitment from Speaker Paul Ryan (R-WI) to bring an immigration bill to the floor.  The Senate agreement, which will be added to the short-term CR through March 23, must be sent back to the House and passed before midnight, Friday morning.

Read more about the deal here and here.

Head of CDC Resigns

Brenda Fitzgerald, Director of the Centers for Disease Control, resigned from her position earlier today because of financial conflicts.

Read more about it here and here.

Azar Confirmed

Alex Azar was confirmed by the Senate earlier this afternoon as the next Secretary of Health and Human Services by a vote of 55 – 43.

Senate to Take Up HHS Nomination

The full Senate is scheduled to take up today the nomination of Alex Azar to serve as Secretary of the Department of Health and Human Services (HHS).  Azar is not a new-comer to the HHS as he served as Deputy Secretary during the George W. Bush Administration.  He has recently been an executive at the pharmaceutical company Eli Lilly and Co.

HHS funds and oversees a host of health-related and biomedical agencies and research programs.  The National Institutes of Health is part of HHS.

Azar was nominated to replace former Secretary Tom Price, who resigned last year.